BioNTech

Clinical Trials Start For New Vaccine For Covid-19 Omicron Variant

Pfizer and BioNTech will start a clinical trial for an Omicron-specific vaccine. The study will include three cohorts of healthy…

3 years ago

Covid-19 Vaccine Manufacturers Say Three Shots ‘Neutralize’ Omicron Variant

Vaccine manufacturers Pfizer and BioNTech have announced that two doses of their Covid-19 vaccine provide significant protection against the rapidly…

3 years ago

Pfizer CEO Albert Bourla Says Third Dose Of COVID-19 Vaccine Is ‘Likely’ Necessary

Pfizer CEO Albert Bourla said that recipients of his company's COVID-19 vaccination, as well as those of similar make-up like…

4 years ago